SLS logo

SLS
SELLAS Life Sciences Group Inc

47,002
Mkt Cap
$248.91M
Volume
4.05M
52W High
$2.48
52W Low
$0.772
PE Ratio
-6.06
SLS Fundamentals
Price
$1.94
Prev Close
$1.99
Open
$1.96
50D MA
$1.83
Beta
1.08
Avg. Volume
2.17M
EPS (Annual)
-$0.5046
P/B
7.64
Rev/Employee
$0.00
Loading...
Loading...
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
15

Frequently Asked Questions

What is Market Cap of SELLAS Life Sciences Group Inc?
What is the 52-week high for SELLAS Life Sciences Group Inc?
What is the 52-week low for SELLAS Life Sciences Group Inc?
What is SELLAS Life Sciences Group Inc stock price today?
What was SELLAS Life Sciences Group Inc stock price yesterday?
What is the PE ratio of SELLAS Life Sciences Group Inc?
What is the Price-to-Book ratio of SELLAS Life Sciences Group Inc?
What is the 50-day moving average of SELLAS Life Sciences Group Inc?
How many employess does SELLAS Life Sciences Group Inc has?

Latest SLS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.